Departments of Endoscopy Pathology Gastroenterology, Fukuoka University Chikushi Hospital Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
Dig Endosc. 2012 Nov;24(6):419-25. doi: 10.1111/j.1443-1661.2012.01314.x. Epub 2012 Apr 12.
Magnifying endoscopy (ME) with narrow-band imaging (NBI) revealed a white opaque substance (WOS) within the superficial part of the gastric neoplasia; however, its nature has remained obscure. A WOS noted within the duodenum was reported to comprise lipid droplets (LD) absorbed by the duodenal epithelium. We attempted to ascertain whether the WOS within gastric neoplasia could also comprise LD and whether the presence of this WOS could be correlated with a specific phenotype.
Forty-three patients with early gastric epithelial neoplasia underwent ME with NBI. The presence or absence of WOS in the neoplasias was recorded based on the findings of ME with NBI. One biopsy specimen was taken from each of the neoplasias. Cryostat sections underwent oil red O staining for LD. Serial sections were immunostained using the first antibody of CD10, MUC2, CDX2, human gastric mucin, MUC5AC and MUC6. The tissue phenotype was classified as intestinal (I), gastric (G) and gastrointestinal (GI) type based on the results of immunostaining. In total, 49 gastric neoplasias from 43 patients were investigated.
Prevalence of LD in WOS-positive versus WOS-negative lesions was 96.2% (25/26) and 4.3% (1/23), respectively (P < 0.001, Fisher's exact test). WOS was present in GI- and I-type lesions, but not in G-type lesions.
WOS may be LD that have been accumulated in the superficial part of the gastric neoplasia of a certain intestinal phenotype.
窄带成像放大内镜(ME-NBI)显示胃黏膜肿瘤的浅层存在白色不透明物质(WOS);然而,其性质尚不清楚。据报道,在十二指肠中观察到的 WOS 由被十二指肠上皮吸收的脂质滴(LD)组成。我们试图确定胃黏膜肿瘤内的 WOS 是否也可以包含 LD,以及这种 WOS 的存在是否可以与特定的表型相关。
43 例早期胃上皮性肿瘤患者接受 ME-NBI 检查。根据 ME-NBI 的发现,记录肿瘤内是否存在 WOS。每个肿瘤均取 1 个活检标本。进行油红 O 染色以检测 LD。使用第一抗体 CD10、MUC2、CDX2、人胃粘蛋白、MUC5AC 和 MUC6 对连续切片进行免疫染色。根据免疫染色的结果,将组织表型分为肠型(I)、胃型(G)和胃肠型(GI)。共对 43 例患者的 49 个胃肿瘤进行了研究。
WOS 阳性病变中存在 LD 的比例为 96.2%(25/26),WOS 阴性病变中存在 LD 的比例为 4.3%(1/23)(P<0.001,Fisher 确切检验)。WOS 存在于 GI 和 I 型病变中,但不存在于 G 型病变中。
WOS 可能是在特定肠型胃黏膜肿瘤浅层积聚的 LD。